Ameritas Investment Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Ameritas Investment Partners's CLB Position: Q2 2026 in Review
Ameritas Investment Partners held its Core Laboratories (CLB) position steady in Q2 2026 at 3,925 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.
Ameritas Investment Partners first reported a position in CLB in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.66M in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Ameritas Investment Partners held 3,925 shares of Core Laboratories worth $45.7K as of Q2 2026.
- Ameritas Investment Partners left its Core Laboratories share count unchanged in Q2 2026.
- Core Laboratories made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2307 holding.
- Ameritas Investment Partners first reported a position in Core Laboratories in Q4 2015 and has held it in 29 quarters since.
- Ameritas Investment Partners's Core Laboratories position peaked at $1.66M in Q2 2018.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.